Recent Security Class Actions

Infinity Pharmaceuticals Inc. Common Stock (NASDAQ: INFI)

Company Name:Infinity Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: INFI
Class Period Start:01/05/2022
Class Period End (inclusive):07/24/2023
Filing Deadline:10/16/2023

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Infinity overstated its prospects for a breast cancer treatment; (2) Infinity was overly optimistic about its breast cancer studies; (3) all the foregoing, once revealed, was likely to negatively impact Infinity's business, financial results, and reputation; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.